Skip to content
OpenCapital
Get started

Bionano Genomics, Inc. BNGO Q4 2024 Annual earnings

Reported March 31, 2025 · After market close

Revenue$8.2MBeat by $2.0M
EPS-$57.49Miss by $51.49
Revenue estimate$6.2M
EPS estimate-$6.00

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$7.6M
EPS estimate-$0.70

Versus estimates

Revenue

Q1 2026$6.7MBeat by $119.5KQ4 2025$8.0MBeat by $71.5KQ3 2025$7.4MMiss by $533.0KQ2 2025$6.7MMiss by $489.5KQ1 2025$6.5MBeat by $207.0K
Q4 2024$8.2MBeat by $2.0M

Diluted EPS

Q1 2026-$0.76Beat by $0.05Q4 2025-$0.03Beat by $0.78Q3 2025-$1.59Beat by $0.22Q2 2025-$1.99Beat by $0.70Q1 2025-$1.15Beat by $2.34
Q4 2024-$57.49Miss by $51.49

Ask the moment Bionano Genomics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bionano Genomics, Inc. report Q4 2024 earnings?
Bionano Genomics, Inc. (BNGO) reported Q4 2024 earnings on March 31, 2025 after market close.
What were Bionano Genomics, Inc.'s Q4 2024 revenue and EPS?
Bionano Genomics, Inc. reported revenue of $8.2M and eps of $-57.49 for Q4 2024.
Did Bionano Genomics, Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $6.2M by $2.0M. EPS missed the consensus estimate of $-6.00 by $51.49.
Where can I find Bionano Genomics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001411690-25-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.